Fredun Pharmaceuticals Limited

FREDUN

Small Cap | Pharmaceuticals
1648
-16.75 (-1%)

Stock price as on 06 Feb 2026 at 15:30 PM

Fredun pharmaceuticals limited share price update

As of the latest trading session, Fredun Pharmaceuticals Limited share price is currently at ₹1648, which is down by ₹-16.75 from its previous closing...

Fredun Pharmaceuticals Limited stock performance

Today’s low

₹1,587.6

Today’s high

₹1,665

₹1,648

52 week low

₹635.05

52 week high

₹1,999

₹1,648
Open
₹1,664.75
Previous close
₹1,664.75
Share volume
14,228
Total traded value (Lakh)
₹232.58
Upper circuit
₹1,997.70
Lower circuit
₹1,331.80

Fredun Pharmaceuticals Limited fundamentals

Market cap (Cr)
₹884.30
P/E ratio (TTM)
30.6
Book value per share
₹443.74
Beta
0.65
Return on equity
14.34%
Earnings per share (TTM)
₹53.86
Dividend yield
0.04%
Net profit/quarter (Cr)
₹9.73

Fredun Pharmaceuticals Limited financials

(Values in Cr)
Revenue
Net income

Particulars

Sep 25 (₹ value in crores)

Revenue

₹143.59

Operating expense

₹132.28

Net income

₹9.73

Net profit margin

6.77%

Earning per share

₹20.61

EBITDA

₹22.34

Effective tax rate

25.13%

Particulars

Jun 25 (₹ value in crores)

Revenue

₹119.40

Operating expense

₹110.81

Net income

₹6.77

Net profit margin

5.67%

Earning per share

₹14.33

EBITDA

₹16.99

Effective tax rate

25.11%

Particulars

Mar 25 (₹ value in crores)

Revenue

₹165.44

Operating expense

₹159.37

Net income

₹7.07

Net profit margin

4.27%

Earning per share

₹14.98

EBITDA

₹17.43

Effective tax rate

12.06%

Particulars

Dec 24 (₹ value in crores)

Revenue

₹101.84

Operating expense

₹95.56

Net income

₹5.33

Net profit margin

5.23%

Earning per share

₹11.29

EBITDA

₹13.21

Effective tax rate

25.24%

Particulars

Sep 24 (₹ value in crores)

Revenue

₹106.89

Operating expense

₹99.78

Net income

₹4.27

Net profit margin

3.99%

Earning per share

₹9.05

EBITDA

₹13.95

Effective tax rate

43.53%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

₹451.71

Operating expense

₹428.00

Net income

₹20.81

Net profit margin

4.6%

Earning per share

₹44.83

EBITDA

₹55.10

Effective tax rate

26.38%

Particulars

Mar 24 (₹ value in crores)

Revenue

₹346.58

Operating expense

₹327.62

Net income

₹15.62

Net profit margin

4.5%

Earning per share

₹33.32

EBITDA

₹38.90

Effective tax rate

27.17%

Particulars

Mar 23 (₹ value in crores)

Revenue

₹274.34

Operating expense

₹258.99

Net income

₹10.81

Net profit margin

3.94%

Earning per share

₹22.93

EBITDA

₹29.59

Effective tax rate

38.26%

Particulars

Mar 22 (₹ value in crores)

Revenue

₹221.74

Operating expense

₹217.48

Net income

₹6.34

Net profit margin

2.85%

Earning per share

₹14.29

EBITDA

₹15.43

Effective tax rate

26.27%

Particulars

Mar 21 (₹ value in crores)

Revenue

₹131.55

Operating expense

₹130.92

Net income

₹2.01

Net profit margin

1.52%

Earning per share

₹5.05

EBITDA

₹9.37

Effective tax rate

37.07%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹255.15

Return on Equity (ROE)

14.34%

Return on Capital Employed (ROCE)

16.95%

Total debt to equity ratio

0.88

EBITDA margin

11.17%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹194.27

Return on Equity (ROE)

13.15%

Return on Capital Employed (ROCE)

17.43%

Total debt to equity ratio

0.85

EBITDA margin

10.78%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹153.07

Return on Equity (ROE)

11.41%

Return on Capital Employed (ROCE)

12.9%

Total debt to equity ratio

0.83

EBITDA margin

6.91%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹107.96

Return on Equity (ROE)

4.76%

Return on Capital Employed (ROCE)

9.34%

Total debt to equity ratio

0.88

EBITDA margin

7.16%

Particulars (annual)

Mar 20 (₹ value in crores)

Book value per share

₹103.57

Return on Equity (ROE)

4.73%

Return on Capital Employed (ROCE)

10.16%

Total debt to equity ratio

0.67

EBITDA margin

7.85%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹1.35

Total assets

₹307.59

Total liabilities

₹307.59

Total equity

₹121.47

Shares outstanding

₹0.46

Price to book ratio

₹2.81

Return on assets (%)

5.07%

Return on capital

6.88%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹3.43

Total assets

₹257.27

Total liabilities

₹257.27

Total equity

₹96.37

Shares outstanding

₹0.45

Price to book ratio

₹4.00

Return on assets (%)

4.2%

Return on capital

5.91%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹2.07

Total assets

₹186.98

Total liabilities

₹186.98

Total equity

₹68.06

Shares outstanding

₹0.44

Price to book ratio

₹5.98

Return on assets (%)

3.38%

Return on capital

5.24%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹1.12

Total assets

₹161.61

Total liabilities

₹161.61

Total equity

₹43.07

Shares outstanding

₹0.39

Price to book ratio

₹4.29

Return on assets (%)

1.24%

Return on capital

2.44%

Particulars

Mar 20 (₹ value in crores)

Cash and short term investments

₹3.05

Total assets

₹141.37

Total liabilities

₹141.37

Total equity

₹41.32

Shares outstanding

₹0.39

Price to book ratio

₹1.13

Return on assets (%)

1.34%

Return on capital

2.5%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 24 (₹ value in crores)

Net income

₹15.62

Cash from operations

-₹0.43

Cash from investing

-₹7.63

Cash from financing

₹5.99

Net change in cash

-₹2.08

Free cash flow

₹7.20

Particulars

Mar 23 (₹ value in crores)

Net income

₹10.75

Cash from operations

-₹14.40

Cash from investing

-₹9.40

Cash from financing

₹25.17

Net change in cash

₹1.36

Free cash flow

-₹4.91

Particulars

Mar 22 (₹ value in crores)

Net income

₹6.31

Cash from operations

-₹2.38

Cash from investing

-₹4.14

Cash from financing

₹7.46

Net change in cash

₹0.94

Free cash flow

₹1.90

Particulars

Mar 21 (₹ value in crores)

Net income

₹2.01

Cash from operations

₹0.16

Cash from investing

-₹1.38

Cash from financing

-₹0.71

Net change in cash

-₹1.93

Free cash flow

₹1.55

Particulars

Mar 20 (₹ value in crores)

Net income

₹2.34

Cash from operations

-₹10.61

Cash from investing

-₹1.49

Cash from financing

₹13.72

Net change in cash

₹1.59

Free cash flow

-₹9.12

Fredun Pharmaceuticals Limited technical summary

₹1648
-1 ▼
16
Bearish
0
Bullish
5 Day1,629
10 Day1,594.7
12 Day1,585.9
20 Day1,572.6
26 Day1,574.5
50 Day1,585.1
100 Day1,516.9
200 Day1,332.3
5 Day1,636.9
10 Day1,575.4
12 Day1,561.3
20 Day1,530
26 Day1,531.3
50 Day1,633.3
100 Day1,587.5
200 Day1,241.6

1663.28

PIVOT

First support
₹0.00
First resistance
₹0.00
Second support
₹0.00
Second resistance
₹0.00
Third support
₹0.00
Third resistance
₹0.00
RSI
59.06
ADX
19.74
MACD
11.39
Williams % R
-16.25
Commodity Channel Index (CCI)
136.78
Date
06 Feb 2026
Same day
2,676
Week
4,715
Month
6,292
1 year
0.66
3 years
0.66
Over 1 month
7.27%
Over 1 year
124%
Over 3 months
6.43%
Over 3 years
18.54%
Over 6 months
47.28%
Over 6 years
26.84%

Investment Returns

Over 1 Month7.27%
Over 3 Months6.43%
Over 6 Months47.28%
Over 1 Year124%

Fredun Pharmaceuticals Limited Shareholding pattern


Public
53%
Promoter holdings
43.05%
FII
0.46%
DII
3.48%
Promoter shares
0%
Promoter sharesShareCategory

Daulat Nariman Medhora

14,10,898 (26.29%)

Shareholding of Promoter and Promoter Group

Nariman Medhora

7,19,815 (13.41%)

Shareholding of Promoter and Promoter Group

Nikhil Kishorchandra Vora

3,01,010 (5.61%)

Public Shareholding

Fredun Nariman Medhora

1,79,672 (3.35%)

Shareholding of Promoter and Promoter Group

Capri Global Holdings Private Limited

80,000 (1.49%)

Public Shareholding

Promoter sharesShareCategory
Daulat Nariman Medhora14,10,898 (26.29%)Shareholding of Promoter and Promoter Group
Nariman Medhora7,19,815 (13.41%)Shareholding of Promoter and Promoter Group
Nikhil Kishorchandra Vora3,01,010 (5.61%)Public Shareholding
Fredun Nariman Medhora1,79,672 (3.35%)Shareholding of Promoter and Promoter Group
Capri Global Holdings Private Limited80,000 (1.49%)Public Shareholding
Bank Of India75,000 (1.4%)Public Shareholding
Nav Capital Vcc-nav Capital Emerging Star Fund56,000 (1.04%)Public Shareholding

About Fredun Pharmaceuticals Limited

Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals Limited (FPL) was converted into a public limited company in Mar.'94. The Company was promoted by Nariman Medhora and Daulat N Medhora. The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations. Since 1993, D N Pharma's operations were phased out in order to switch over the business to FPL. The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy. The

Parent Organisation

Indian Private

NSE Symbol

Fredun Pharmaceuticals Limited

Founded

1987

Fredun Pharmaceuticals Limited CORPORATE ACTION

Dividend dateDividend amountDividend typeRecord dateInstrument type
23 Sept 20250.7Final23 Sept 2025Equity shares
23 Sept 20240.7Final23 Sept 2024Equity shares
22 Sept 20230.7Final22 Sept 2023Equity shares
16 Sept 20210.7Final18 Sept 2021Equity shares
16 Sept 20190.65Final18 Sept 2019Equity shares
18 Sept 20180.6Final21 Sept 2018Equity shares
20 Sept 20170.6Final22 Sept 2017Equity shares
11 Apr 20160.6Interim13 Apr 2016Equity shares

View more stocks

What’s trending

All stocks

LOYALTEX

LOYAL TEXTILE MILLS LTD.

304.8
+50.8 (+20%)
GORANIN

GORANI INDUSTRIES LTD.

63.61
+10.6 (+20%)
NIRAJISPAT

NIRAJ ISPAT IND LTD

257.41
+42.9 (+20%)
STRATMONT

STRATMONT INDUSTRIES LIMITED

90.01
+15 (+20%)
View all

Top gainers

ITC

ITC LTD

325.8
+15.60 (+5.03%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

422.35
+13.60 (+3.33%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2424.2
+69.80 (+2.96%)
BHARTIARTL

BHARTI AIRTEL LIMITED

2038.4
+46.00 (+2.31%)
View all

Top losers

HDFCLIFE

HDFC LIFE INS CO LTD

703.5
-17.20 (-2.39%)
TCS

TATA CONSULTANCY SERV LT

2941.6
-49.90 (-1.67%)
TECHM

TECH MAHINDRA LIMITED

1619.9
-26.30 (-1.60%)
BAJAJ-AUTO

BAJAJ AUTO LIMITED

9518.5
-128.50 (-1.33%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)